PHASE I TRIAL OF DNX-2401 ONCOLYTIC ADENOVIRUS COMBINED WITH A SHORT COURSE OF DOSE-DENSE TEMOZOLOMIDE FOR RECURRENT GLIOBLASTOMA

被引:0
|
作者
Perez-Larraya, J. Gallego [1 ]
Garcia-Moure, M. [2 ]
Gonzalez-Huarriz, M. [2 ]
Zalacain, M. [2 ]
Marrodan, L. [2 ]
Puigdelloses, M. [2 ]
Labiano, S.
de la Nava, D. [2 ]
Laspidea, V. [2 ,3 ]
Ausejo, I. [2 ]
Hervas, I. [2 ]
Esparragosa, I. [1 ]
Giraldez, M. [1 ]
Dominguez, P. [1 ]
Martinez-Simon, A. [1 ]
Idoate, M. [1 ]
Fueyo, J. [4 ]
Gomez-Manzano, C. [4 ]
Patino, A. [1 ]
Diez-Valle, R. [5 ]
Tejada, S. [5 ]
Alonso, M.
机构
[1] Clin Univ Navarra, Pamplona, Spain
[2] Ctr Appl Med Res, Pamplona, Spain
[3] Univ Navarra, Pamplona, Spain
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[5] Quiron Hosp, Madrid, Spain
关键词
D O I
10.1093/neuonc/noad137.404
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P17.14.B
引用
收藏
页码:120 / 120
页数:1
相关论文
共 50 条
  • [41] Vinorelbine combined with a protracted course of temozolomide for recurrent brain Metastases: a phase I trial
    A.M. Omuro
    J.J. Raizer
    A. Demopoulos
    M.G. Malkin
    L.E. Abrey
    Journal of Neuro-Oncology, 2006, 78 : 277 - 280
  • [42] Vinorelbine combined with a protracted course of temozolomide for recurrent brain Metastases: a phase I trial
    Omuro, A. M.
    Raizer, J. J.
    Demopoulos, A.
    Malkin, M. G.
    Abrey, L. E.
    Abrey, L. E.
    JOURNAL OF NEURO-ONCOLOGY, 2006, 78 (03) : 277 - 280
  • [43] Phase II study of adjuvant dose-dense temozolomide (TMZ) for glioblastoma after surgery and radiochemotherapy
    Ramus, Vietti G.
    Tonda, L.
    Sirgiovanni, M. P.
    Addeo, A.
    Monetti, U.
    Coverlizza, S.
    ANNALS OF ONCOLOGY, 2006, 17 : XI60 - XI61
  • [44] SAFETY, EFFICACY, AND SURVIVAL RESULTS FROM A PHASE 1 STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 FOLLOWED BY STANDARD OF CARE RADIOTHERAPY FOR NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
    Gallego Perez-Larraya, Jaime
    Garcia-Moure, Marc
    Patino-Garcia, Ana
    Gonzalez-Huarriz, Marisol
    Van der Lugt, Jasper
    Astigarraga, Itziar
    Garcia-Ariza, Miguel
    Lopez-Ibor, Blanca
    Jones, Chris
    Mackay, Alan
    Diez-Valle, Ricardo
    Fueyo, Juan
    Gomez-Manzano, Candelaria
    Dobbs, Jessica
    Ewald, Brett
    Alonso, Marta
    Tejada, Sonia
    NEURO-ONCOLOGY, 2021, 23 : 50 - 51
  • [45] PHASE II TRIAL OF DOSE-DENSE 1 WEEK ON/1 WEEK OFF TEMOZOLOMIDE FOR PATIENTS WITH RECURRENT HIGH GRADE GLIOMA
    Han, Seunggu
    Molinaro, Annette
    Berger, Mitchel
    Prados, Michael
    Chang, Susan
    Clarke, Jennifer
    Butowski, Nicholas
    NEURO-ONCOLOGY, 2013, 15 : 111 - 111
  • [46] PRELIMINARY RESULTS OF A PHASE I/II TRIAL OF SELINEXOR AND TEMOZOLOMIDE IN RECURRENT GLIOBLASTOMA
    Chow, Frances
    Berens, Michael
    Palmer, Joycelynne
    Villalona-Calero, Miguel
    Ney, Douglas
    de la Fuente, Macarena
    Jaeckle, Kurt
    Kizilbash, Sani H.
    Nasany, Ruham Alshiekh
    Hrachova, Maya
    Porter, Alyx B.
    Piccioni, David
    Hoang, Kimberly
    Lipinski, Lindsay
    Strowd, Roy
    Giglio, Pierre
    Mantica, Megan
    Schiff, David
    Gore, Steven
    Portnow, Jana
    NEURO-ONCOLOGY, 2024, 26
  • [47] Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma
    McCracken, D. Jay
    Celano, Emma C.
    Voloschin, Alfredo D.
    Read, William L.
    Olson, Jeffrey J.
    JOURNAL OF NEURO-ONCOLOGY, 2016, 130 (01) : 193 - 201
  • [48] Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma
    D. Jay McCracken
    Emma C. Celano
    Alfredo D. Voloschin
    William L. Read
    Jeffrey J. Olson
    Journal of Neuro-Oncology, 2016, 130 : 193 - 201
  • [49] Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial
    Peters, Katherine B.
    Vredenburgh, James J.
    Desjardins, Annick
    Friedman, Henry S.
    Herndon, James Emmett
    Coan, April D.
    McSherry, Frances
    Lipp, Eric S.
    Brickhouse, Alise
    Massey, Woody C.
    Reardon, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] Weekly dose-dense paclitaxel and carboplatin in recurrent ovarian carcinoma: A phase II trial
    Shawky, Hanan
    Tawfik, Hesham
    Hewidy, Medhat
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2014, 26 (03) : 139 - 145